US Patent:
20120315641, Dec 13, 2012
Inventors:
Steven M. Dubinett - Los Angeles CA, US
Brian K. Gardner - Los Angeles CA, US
David Elashoff - Los Angeles CA, US
Kostyantyn Krysan - Los Angeles CA, US
International Classification:
G01N 33/574
G06F 19/10
C12Q 1/68
Abstract:
Disclosed herein are methods, devices and kits for detecting, diagnosing, or categorizing a subject as having lung cancer. As disclosed herein, at least three of the following protein biomarkers: VEGF, CGSF, MIG, RANTES, IL-2, IL-3 and MDC, are used to determine whether a subject at high-risk for lung cancer likely has lung cancer, such as stage I non-small cell lung cancer.